AZD5305 hADME in Patients With Advanced Solid Malignancies

NCT06713369 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumor

Interventions

DRUG: Saruparib (AZD5305)
DRUG: [14C]-AZD5305 microtracer
DRUG: [14C]-AZD5305 (therapeutic dose)

Sponsor

AstraZeneca

Collaborators

[object Object]